Lpl Financial LLC Vir Biotechnology, Inc. Transaction History

Lpl Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$8.6 - $11.9 $264,312 - $365,734	30,734 New	30,734 $311,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $198,285 - $337,714	10,859 New	10,859 $209,000
Q2 2021 Aug 13, 2021	SELL	$38.75 - $51.0 $216,922 - $285,498	-5,598 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$26.34 - $83.07 $147,451 - $465,025	5,598 New	5,598 $287,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.